Biomapas Logo
cropped-favicon-biomapas.png

Medical Device Registration in Russia. The Essentials

Successful Medical Device Registration in Russia The Essentials

Webinar: Successful Medical Device Registration in Russia. The Essentials

The current national system for Medical Device registration in Russia was created from scratch and entered into force in 2013. Most experts agree that this system is complex and puzzling – some critical points are not well documented, some regulatory requirements are ambiguous and unwritten rules play an essential role during the process.

 

The purpose of this webinar is to explain the Medical Device registration procedure in Russia.

 

You will learn about:

  1. Russian Competent Authorities in the medical device field
  2. State Legislation and levels of legislation
  3. The scheme of State registration
  4. The registration dossier and list of the documents
  5. Testing and evaluation (technical, toxicological, clinical)
  6. Post-registration activity
  7. Role of an Authorized Representative of the manufacturer

 

Expanding into the Russian market?

Make use of our experts to guide you from the start to a full market access. Explore your options in a chat with one of our experts.

Let's Talk

Who should attend? Professionals from Medical Device companies working within:

  • Regulatory
  • R&D
  • QA/QC
  • Compliance
  • Product Development
  • Manufacturing

Duration: 50 min.

Speaker: Regulatory Affairs Project Manager, Mikhail Vinogradov, LLM, who will share his experience on registering Medical Devices in Russia.

Mikhail Vinogradov, LLM

Mikhail Vinogradov, LLM

Regulatory Affairs Project Manager

Other content that might interest you:

Regulatory Strategy in the EAEU and rest of CIS Countries

Regulatory Strategy in the EAEU and rest of CIS Countries

Webinar: Regulatory Strategy in the EAEU and Rest of CIS Countries Regulatory strategy in EAEU and CIS regions differ from other regions as market access to these countries can be a real challenge due to various local regulations. However, it is only a matter of...

CMC: Effective Writing Of IND And IMPD

CMC: Effective Writing Of IND And IMPD

Do we truly know how to ensure a well-written IND or IMPD Quality (CMC) part? Consistent and clear technical language? How to effectively manage the writing process? Biomapas can help you answer these questions and to set up the initial IND/IMPD required to start...

Effective IMPD Writing. The Quality Part

Effective IMPD Writing. The Quality Part

Webinar: Effective IMPD Writing. The Quality Part Effective IMPD writing, including the quality part is a vital document that contains information about an investigational medicinal product and it is an essential part of the Clinical Trial Application (CTA), which is...

Expediting access through Reliance Pathways: MENA region

Expediting access through Reliance Pathways: MENA region

Reliance models are review pathways used by Regulators to expedite the patient access to essential pharmaceutical products and to overcome resource constraints and priorities.   Recently, several National Competent Authorities (NCA) in the Middle East North Africa...

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.
Affiliate-Based Outsourcing
CSV For Pharmacovigilance Systems
Early Phase Oncology
Functional Service Provision
M&A Support

Clinical Research

Read more

Regulatory Affairs

Read more

Pharmacovigilance

Read more

Medical Information

Read more